PubRank

Bruno Millet

Author PubWeight™ 41.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Increased exonic de novo mutation rate in individuals with schizophrenia. Nat Genet 2011 4.01
2 Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 2010 3.69
3 Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008 3.52
4 Apathy in patients with Parkinson disease without dementia or depression: a PET study. Neurology 2012 1.54
5 [Reduction in short-term repetition of attempted suicide associated with new organization of psychiatric management of suicide attempters. Two cohorts]. Presse Med 2006 1.37
6 Prevalence of smoking in psychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry 2002 1.17
7 Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry 2010 1.17
8 Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze. Behav Brain Res 2006 1.06
9 Psychopathology and comorbidity of psychiatric disorders in patients with kleptomania. Am J Psychiatry 2003 1.06
10 A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study. Eur Psychiatry 2007 1.05
11 Early-onset obsessive-compulsive disorder: a subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry 2005 1.04
12 Neurological soft-signs and minor physical anomalies in schizophrenia: differential transmission within families. Schizophr Res 2003 1.04
13 Animal models relevant to schizophrenia and autism: validity and limitations. Behav Genet 2006 1.02
14 Major depressive disorder skews the recognition of emotional prosody. Prog Neuropsychopharmacol Biol Psychiatry 2011 1.02
15 Admixture analysis of age at onset in obsessive-compulsive disorder. Psychol Med 2005 0.98
16 Subthalamic nucleus stimulation affects limbic and associative circuits: a PET study. Eur J Nucl Med Mol Imaging 2010 0.94
17 Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport 2004 0.94
18 Which placebo to cure depression? A thought-provoking network meta-analysis. BMC Med 2013 0.89
19 Chronic and treatment-resistant depression: a study using arterial spin labeling perfusion MRI at 3Tesla. Psychiatry Res 2010 0.87
20 Paliperidone extended-release in patients with non-acute schizophrenia previously unsuccessfully treated with other oral antipsychotics. Expert Opin Pharmacother 2014 0.87
21 Neuronal activity correlated with checking behaviour in the subthalamic nucleus of patients with obsessive-compulsive disorder. Brain 2013 0.85
22 Neuronal death in Alzheimer's disease and therapeutic opportunities. J Cell Mol Med 2009 0.84
23 Subthalamic nucleus stimulation affects theory of mind network: a PET study in Parkinson's disease. PLoS One 2010 0.84
24 Assessment of standard coil positioning in transcranial magnetic stimulation in depression. Psychiatry Res 2010 0.83
25 Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans. Neurosci Lett 2004 0.81
26 Cognitive impulsivity in Parkinson's disease patients: assessment and pathophysiology. Mov Disord 2009 0.81
27 De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry 2010 0.81
28 Improving study design for antidepressant effectiveness assessment. Int J Methods Psychiatr Res 2013 0.81
29 Association of an UCP4 (SLC25A27) haplotype with ultra-resistant schizophrenia. Pharmacogenomics 2011 0.81
30 Correlation between clinical syndromes and neuropsychological tasks in unmedicated patients with recent onset schizophrenia. Psychiatry Res 2002 0.79
31 Psychopathology in the 21st century. World J Biol Psychiatry 2010 0.78
32 Use of asenapine in clinical practice for the management of bipolar mania. J Psychopharmacol 2013 0.78
33 Neurological soft signs in OCD patients with early age at onset, versus patients with schizophrenia and healthy subjects. J Neuropsychiatry Clin Neurosci 2011 0.78
34 Generalized anxiety disorder is under-recognized in clinical practice in patients with alcohol dependence in France. Alcohol 2012 0.77
35 Pathological gambling secondary to dopaminergic therapy in Parkinson's disease. Psychiatry Res 2006 0.76
36 Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment. Neuropsychiatr Dis Treat 2012 0.75
37 Cardiac risk at the onset of treatment in patients treated with benzodiazepines and clozapine. Eur Psychiatry 2002 0.75
38 Pallidal stimulation in Parkinson's disease does not induce apathy. J Neuropsychiatry Clin Neurosci 2014 0.75
39 Ultra-resistant schizophrenia is not associated with the multidrug-resistant transporter 1 (MDR1) gene rs1045642 variant. J Clin Psychopharmacol 2011 0.75
40 [Acute episode of psychosis during hospitalisation in a medical intensive care unit]. Presse Med 2004 0.75
41 The fallacy of thresholds used in defining response and remission in depression rating scales. Int J Methods Psychiatr Res 2013 0.75